What is semaglutide?
Also known as: Ozempic · Wegovy · Rybelsus
- Route
- Subcutaneous
- Half-life
- ~7 days
- Evidence
- Strong evidence
Prescription GLP-1 agonist sold as Ozempic, Wegovy, and Rybelsus. Discussed around weight and blood sugar.
Semaglutide is a prescription GLP-1 medication, best known under the brand names Ozempic, Wegovy, and Rybelsus. It is a GLP-1 agonist, meaning it mimics a gut hormone tied to appetite and blood sugar.
People most often discuss it in conversations around weight and blood sugar. It has strong clinical evidence behind it, which is why its research tier in TRKD+ is Strong.
Because semaglutide is a prescription medication, any decision about using it, and any dosing, belongs with a licensed healthcare provider. TRKD+ describes what it is and gives you a place to track a regimen you are already on. It does not recommend or prescribe.
Vocabulary
Terms you’ll see with it.
- Protocol
GLP-1 agonist
A class of drugs (semaglutide, tirzepatide) that mimic a gut hormone tied to appetite.
- Protocol
Titration
Easing a dose up or down gradually over weeks, rather than jumping straight to a target.
- Route
Subcutaneous
Injected into the fat layer just under the skin. Short needle, shallow angle.
- Timing
Half-life
How long it takes for half of a dose to clear your system. Drives dosing frequency.
Common questions
People also ask.
- Is semaglutide the same as Ozempic and Wegovy?
- Yes. Ozempic, Wegovy, and Rybelsus are brand names for semaglutide, approved for different uses.
- Is semaglutide a GLP-1 agonist?
- Yes. It mimics the GLP-1 hormone, which is tied to appetite and blood sugar.
- Do I need a prescription for semaglutide?
- Yes. It is a prescription medication, and its use is a decision for a licensed provider.
TRKD+
Track the whole stack, calmly.
Log peptides, GLP-1s, and TRT. Rotate injection sites. Free, private, no ads.